These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2494563

  • 1. Evaluation of recombinant tissue plasminogen activator in embolic stroke.
    Chehrazi BB, Seibert JA, Kissel P, Hein L, Brock JM.
    Neurosurgery; 1989 Mar; 24(3):355-60. PubMed ID: 2494563
    [Abstract] [Full Text] [Related]

  • 2. Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator.
    Kissel P, Chehrazi B, Seibert JA, Wagner FC.
    J Neurosurg; 1987 Sep; 67(3):399-405. PubMed ID: 3112329
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA.
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries.
    Chehrazi BB, Seibert JA, Hein L, Brock J, Kissel P.
    Neurosurgery; 1991 Mar; 28(3):364-9. PubMed ID: 1901394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V, Zabramski JM, Boston M, Puca A, Spetzler RF.
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.
    Russell D, Madden KP, Clark WM, Zivin JA.
    Stroke; 1992 Mar; 23(3):388-93. PubMed ID: 1542901
    [Abstract] [Full Text] [Related]

  • 11. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F, Hilger T, Hoehn M, Hossmann KA.
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging.
    Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M.
    Neurology; 1998 Apr; 50(4):870-5. PubMed ID: 9566365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, Chopp M.
    Circulation; 2003 Jun 10; 107(22):2837-43. PubMed ID: 12756151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.